
CVS beats estimates, but cuts full-year profit outlook on higher medical costs
The company lowered its 2024 adjusted earnings forecast to at least $8.30 per share, down from a previous guidance of at least $8.50 per share.

The 3 Most Undervalued S&P 500 Stocks to Buy in February 2024
Since betting on the individual companies of the Standard and Poor's 500 offers a solid chance for long-term profitability, it stands to reason that going for undervalued S&P 500 stocks could poten...

CVS Health Earnings Are Soon. Medicare Advantage Will Be in Focus.
The company is a major player in the Medicare Advantage business, along with Humana and UnitedHealth.

The 7 Most Undervalued Large-Cap Stocks to Buy in February 2024
The “Magnificent Seven” stocks may garner the lion's share of market attention right now, but while there may be strong potential with some of “Mag 7” names, check out opportunities making far fewe...

Exploring Analyst Estimates for CVS Health (CVS) Q4 Earnings, Beyond Revenue and EPS
Evaluate the expected performance of CVS Health (CVS) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key me...

CVS Health (CVS) Earnings Expected to Grow: Should You Buy?
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is the Worst Over for CVS Health Stock?
CVS Health Corp (NYSE:CVS) stock was last seen up 0.6% at $73.40, extending a bounce off the $70 level.

CVS Health (CVS) Advances While Market Declines: Some Information for Investors
In the closing of the recent trading day, CVS Health (CVS) stood at $73, denoting a +1.4% change from the preceding trading day.

Tyson Foods drops CVS for startup to manage staff pharmacy benefits
Tyson Foods has dropped CVS Health as its pharmacy benefit manager and replaced it with Rightway, the startup said on Wednesday, to manage drug benefits for the meatpacker's 175,000 employees.

Tyson Foods drops CVS for upstart pharmacy benefit manager, as industry upheaval over cost concerns spreads
Tyson Foods drops CVS for startup PBM offering drug price transparency

Is Walgreens Stock's Dividend Safe Now?
A key component of income investing is a portfolio that includes safe dividends, those that are unlikely to shrink or disappear.

Strategist says investors should buy CVS, skip Walgreens
In the latest installment of Yahoo Finance's Good Buy or Goodbye, Julie Hyman is joined by F/m Investments President and CIO Alex Morris to discuss his stock picks to buy and avoid in the healthcar...

CVS Loyalty Chief Says Program Overhaul Driven by Consumer Desire to Keep It Simple
Loyalty programs have become a ubiquitous part of the retail landscape, offering consumers enticing rewards and incentives for sticking with their favorite brands. However, as retailers expand thei...

CVS Health: Back In The Buy Column
CVS Health Corporation's recent acquisitions have transformed the company into a leader in the healthcare services industry. Despite a decrease in COVID-19 vaccination rates and a revision of its f...

CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know
In the most recent trading session, CVS Health (CVS) closed at $73.22, indicating a -0.89% shift from the previous trading day.
Related Companies